Koa Wealth Management LLC boosted its holdings in CME Group Inc. (NASDAQ:CME – Free Report) by 37.1% in the third quarter, according to the company in its most recent Form 13F filing with the SEC. The institutional investor owned 9,658 shares of the financial services provider’s stock after purchasing an additional 2,615 shares during the quarter. CME Group comprises 1.6% of Koa Wealth Management LLC’s holdings, making the stock its 20th largest holding. Koa Wealth Management LLC’s holdings in CME Group were worth $2,131,000 as of its most recent SEC filing.
Other institutional investors have also recently bought and sold shares of the company. Y.D. More Investments Ltd bought a new position in CME Group in the 2nd quarter valued at about $36,000. McClarren Financial Advisors Inc. raised its stake in shares of CME Group by 66.1% in the second quarter. McClarren Financial Advisors Inc. now owns 196 shares of the financial services provider’s stock worth $39,000 after purchasing an additional 78 shares during the last quarter. Asset Dedication LLC lifted its holdings in shares of CME Group by 515.2% in the second quarter. Asset Dedication LLC now owns 203 shares of the financial services provider’s stock valued at $40,000 after purchasing an additional 170 shares in the last quarter. Thurston Springer Miller Herd & Titak Inc. boosted its position in shares of CME Group by 62.2% during the third quarter. Thurston Springer Miller Herd & Titak Inc. now owns 193 shares of the financial services provider’s stock valued at $43,000 after buying an additional 74 shares during the last quarter. Finally, Bank & Trust Co bought a new stake in CME Group during the second quarter worth $76,000. Institutional investors and hedge funds own 87.75% of the company’s stock.
Insider Activity
In other CME Group news, Director Timothy S. Bitsberger sold 1,000 shares of the firm’s stock in a transaction on Wednesday, October 30th. The stock was sold at an average price of $226.96, for a total transaction of $226,960.00. Following the completion of the transaction, the director now owns 10,589 shares of the company’s stock, valued at approximately $2,403,279.44. This trade represents a 8.63 % decrease in their ownership of the stock. The sale was disclosed in a filing with the SEC, which can be accessed through this link. Also, CFO Lynne Fitzpatrick sold 754 shares of the company’s stock in a transaction dated Sunday, September 15th. The stock was sold at an average price of $216.99, for a total transaction of $163,610.46. Following the completion of the sale, the chief financial officer now directly owns 13,261 shares in the company, valued at $2,877,504.39. This represents a 5.38 % decrease in their ownership of the stock. The disclosure for this sale can be found here. Over the last three months, insiders have sold 15,621 shares of company stock valued at $3,441,063. 0.30% of the stock is currently owned by insiders.
CME Group Stock Performance
CME Group (NASDAQ:CME – Get Free Report) last announced its quarterly earnings data on Wednesday, October 23rd. The financial services provider reported $2.68 earnings per share for the quarter, topping analysts’ consensus estimates of $2.65 by $0.03. CME Group had a net margin of 57.34% and a return on equity of 13.39%. The firm had revenue of $1.58 billion during the quarter, compared to analyst estimates of $1.59 billion. During the same period in the previous year, the business posted $2.25 EPS. The business’s quarterly revenue was up 18.4% on a year-over-year basis. On average, sell-side analysts predict that CME Group Inc. will post 10.23 earnings per share for the current fiscal year.
CME Group Dividend Announcement
The firm also recently declared a quarterly dividend, which will be paid on Friday, December 27th. Shareholders of record on Monday, December 9th will be given a dividend of $1.15 per share. The ex-dividend date of this dividend is Monday, December 9th. This represents a $4.60 annualized dividend and a yield of 2.04%. CME Group’s payout ratio is 48.37%.
Wall Street Analysts Forecast Growth
Several brokerages have weighed in on CME. Piper Sandler raised their price objective on CME Group from $240.00 to $250.00 and gave the company an “overweight” rating in a research note on Monday, October 28th. Royal Bank of Canada reissued a “sector perform” rating and set a $235.00 price target on shares of CME Group in a research report on Thursday, October 24th. Keefe, Bruyette & Woods upped their price objective on shares of CME Group from $212.00 to $213.00 and gave the stock a “market perform” rating in a research report on Thursday, July 25th. Citigroup increased their price objective on shares of CME Group from $250.00 to $255.00 and gave the company a “buy” rating in a research note on Thursday, October 24th. Finally, Barclays boosted their target price on CME Group from $219.00 to $231.00 and gave the stock an “equal weight” rating in a research note on Thursday, October 24th. Four analysts have rated the stock with a sell rating, seven have assigned a hold rating and four have assigned a buy rating to the company. According to data from MarketBeat, the stock has a consensus rating of “Hold” and a consensus target price of $224.47.
Read Our Latest Stock Analysis on CME Group
CME Group Company Profile
CME Group Inc, together with its subsidiaries, operates contract markets for the trading of futures and options on futures contracts worldwide. It offers futures and options products based on interest rates, equity indexes, foreign exchange, agricultural commodities, energy, and metals, as well as fixed income and foreign currency trading services.
Further Reading
- Five stocks we like better than CME Group
- Top Stocks Investing in 5G Technology
- Freeport-McMoRan, Copper Demand Short-Term Pain, Long-Term Gain
- Best ESG Stocks: 11 Best Stocks for ESG Investing
- Time to Load Up on Home Builders?
- 3 Small Caps With Big Return Potential
- Flutter Entertainment Can Be a Blue-Chip Sports Betting Stock
Want to see what other hedge funds are holding CME? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for CME Group Inc. (NASDAQ:CME – Free Report).
Receive News & Ratings for CME Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for CME Group and related companies with MarketBeat.com's FREE daily email newsletter.